Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04672421
Other study ID # UMT2009-SP-ASMC-0301
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 18, 2011
Est. completion date May 9, 2012

Study information

Verified date September 2021
Source Shin Poong Pharmaceutical Co. Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was designed to assess the safety and efficacy of MEDICURTAIN. Patients who underwent total laparoscopic hysterectomy were randomly assigned either into Medicurtain® treatment group or non-treatment control group. Adhesion formations at 8 weeks after the index surgery were compared between the two groups by using the well-defined grade scale and image recording.


Description:

This study was designed as multi-center, randomized, evaluator-blinded, comparative study. Subjects were woman between 20~80 years of age reserved with total laparoscopic hysterectomy. Subject screening was conducted for the subject who signed an informed consent form. Subjects who met the inclusion criteria were randomly assigned into either treatment (Medicurtain®) or control group. Each subject visit clinic for follow-up examination 1week (Visit 2) and 8 weeks (Visit 3) after the index surgery and before the visit subjects were received phone calls. Since the target population was the patient who scheduled elective total laparoscopic hysterectomy, subjects who met the inclusion/exclusion criteria after the examination for the surgery signed on the informed consent at Visit 1 (Baseline: 0 day) and randomly assigned either into the treatment and control group. At visit 2 (1week±2days), 1week after the index surgery adverse events and general health were examined. At visit 3 (8week±5days), 8 weeks after the index surgery, the investigator inserted endoscope into abdominal cavity and took video clip and still images. If it was necessary, adhesion was removed surgically. An independent evaluator evaluated the records and graded the adhesion rate and its severity according to the grading system. If it was difficult to collect images with endoscope, the investigators recorded his observation for statistical analysis. The investigator inserted endoscope into abdominal cavity and took video clip and still images at 8weeks after total laparoscopic hysterectomy to evaluate the adhesion formation and its grade. An independent evaluator evaluated the records and graded the adhesion rate and its severity according to the grading system. If it was difficult to collect images with endoscope, the investigators recorded his observation for statistical analysis. The adhesion grading system was proposed by American Fertility Society (AFS) in 1988, grades adhesion with Grade 0, Grade 1, Grade2 and Grade 3. Grade 0 means there is no adhesion formation, Grade 1~Grade 3 means there is adhesion formed, severity increases with the grade. Adhesion rate and grade were evaluated between the treatment and control groups suing Grade 0~3 scales. General safety of the study device was evaluated based on the adverse event rate, laboratory tests, ECG test. The laboratory tests were conducted before and after the index surgery to evaluate whether the device cause toxicity such as hepatic and renal toxicity for safety evaluation.


Recruitment information / eligibility

Status Completed
Enrollment 107
Est. completion date May 9, 2012
Est. primary completion date May 9, 2012
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - Woman who is between 20~80 years of age. - Woman who is reserved with total laparoscopic hysterectomy like: - Malignant neoplasm of cervix - Malignant neoplasm of uterine body - Unspecified malignant neoplasm of cervical region - Other and unspecified malignant neoplasm of the female reproductive system - Carcinoma in situ of the cervix - Other and unspecified carcinoma in situ of the reproductive system Leiomyoma of the uterus - Other benign neoplasms of uterus - Neoplasm of uncertain behavior of uterus - Endometriosis - Polyp of corpus uteri - Other noninflammatory disorders of uterus, except cervix - Cervical dysplasia - Congenital malformations of uterus and cervix - Injury of uterus - Woman who signed and informed consent. Exclusion Criteria: - Presence of tumor or inflammatory disease in other organs after the laparoscopy or laparoscopic surgery - Subjects with a history of open surgery or laparoscopic surgery - Subject who is not eligible for anesthesia or re-operation due to other disease confirmed by investigator - Subject who is not eligible for re-operation or laparoscopy after laparoscopic surgery - Subjects using coagulant and subjects with lymphoid disease - Diabetic subjects administrating oral or parenteral glucose-lowering drugs - Patients with autoimmune diseases or immune disorders - Liver disease or kidney disease, surgical subjects including open surgery of gastrointestinal or urinary system - Subjects judged as inadequate by investigator

Study Design


Intervention

Device:
Medicurtain®
Anti-adhesion barrier (Medicurtain® 5ml prefilled syringe after laparoscopic surgery)
Placebo
No device after laparoscopic surgery

Locations

Country Name City State
Korea, Republic of Asan Medical Center Seoul Seoul Asan Medical Center Gil, Songpa-gu

Sponsors (1)

Lead Sponsor Collaborator
Shin Poong Pharmaceutical Co. Ltd.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other The incidence rate of adverse events Safety and tolerability by collecting adverse events (AEs) follow up to 8 weeks
Other The incidence rate of adverse device event Safety and tolerability by collecting adverse device event (ADEs) follow up to 8 weeks
Other The incidence rate of serious adverse events Safety and tolerability by collecting serious adverse events (SAEs) follow up to 8 weeks
Other QT interval on a 12-lead electrocardiogram (ECG) tracing Change From baseline in QT Interval follow up to 8 weeks
Primary Comparison of the adhesion rate between the groups Adhesion rate = (number of subjects who developed adhesion in a group)/ (Total number of subjects for each group) 8 weeks after surgery
Secondary Comparison of adhesion grade based on the severity between the groups Adhesive grade evaluation standards are classified into Grade 0(None), Grade 1(Mild), Grade 2(Moderate), Grade 3(Severe). 8 weeks after surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04515485 - A Volumetric Nomogram for Height, Weight, and Intra Abdominal Volume
Completed NCT01725477 - Laparoscopic Tubal Patency Assessment N/A
Recruiting NCT01093430 - Is the Anterior Superior Iliac Spine a Useful Landmark at Laparoscopy? N/A
Recruiting NCT01093079 - Laparoscopic Versus Open Partial Nephrectomy - Surgical and Oncological Outcomes N/A
Completed NCT00535990 - Minimally Invasive Surgery (MIS) Database for the Purpose of Research
Completed NCT01092013 - Comparative Evaluation of Simulator Based and Traditional In-surgery Laparoscopic Camera Training's Efficiency in Novices N/A
Recruiting NCT06044909 - Multimodal Image Registration for Helping Laparoscopic Liver Surgery Guidance
Completed NCT06255080 - Comparing Skills Acquisition on Different Laparoscopy Software N/A
Not yet recruiting NCT05389241 - Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial N/A
Enrolling by invitation NCT03234543 - Remote Ischemic Conditioning in Abdominal Surgery N/A
Recruiting NCT02827292 - Effect of Music on Inflammatory Response During Laparoscopic Surgery N/A
Not yet recruiting NCT06092684 - The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery Phase 3
Terminated NCT01008709 - Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery N/A
Active, not recruiting NCT05363813 - Post-market Clinical Follow-up Study of Reusable Clip Applier Cartridge Devices for LAParoscopic Surgery N/A
Completed NCT03330236 - EEG - Guided Anesthetic Care and Postoperative Delirium N/A
Recruiting NCT05031182 - Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique. N/A
Active, not recruiting NCT05302622 - Detecting the Most Efficient Residency Time for Laparoscopic Simulators N/A
Recruiting NCT03684291 - Hemodynamic Effects of Ventilation Modes
Recruiting NCT06117748 - Volume-Controlled Ventilation and Pressure-Controlled Ventilation Volume Guaranteed in Obese Patients in Laparoscopic-Assisted Surgery N/A
Recruiting NCT03739944 - Different Surgical Approaches in Patients of Early-stage Cervical Cancer Phase 3